Pharma companies offer $26B to resolve opioid litigation

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

The deal is $4 billion more than an offer made in 2015 that was rejected by many states and municipalities. The upgraded offer includes $2 billion for private attorneys representing cities, counties and some of the states..

” The offer gets cash to all of the neighborhoods in the United States that are suffering from insult upon injury, first from the opioid epidemic and now with COVID too,” stated Paul Hanly Jr., an attorney who represents numerous little federal governments, according to the Times..

Read the full article here..

If the deal is accepted, the 4 companies would no longer be at danger of future opioid lawsuits from the accuseds, the Times reported. Other pharmaceutical companies are still facing thousands of opioid-related lawsuits..

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

More posts on opioids: Federal district attorneys urge court to close North Carolina drug store for extreme opioid dispensingDocuments show Sackler familys involvement in opioid operationsWalmart pre-emptively takes legal action against United States as part of opioid lawsuits fight.

Mckesson, Cardinal Health, AmerisourceBergen and Johnson & & Johnson have used a $26 billion handle states and regional governments to end the countless suits against the pharma companies for their functions in the opioid crisis, The New York Times reported.

Maia Anderson –
Friday, November 6th, 2020
Print|Email.

Most of the $26 billion is intended to spend for addiction treatment and avoidance programs. Each state would identify how it would distribute the money..